<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37661534</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>44</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.</ArticleTitle><Pagination><StartPage>6514</StartPage><EndPage>6528</EndPage><MedlinePgn>6514-6528</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2023.08.022</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(23)00954-4</ELocationID><Abstract><AbstractText>New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged, imposing the need for periodic booster doses. However, whether booster doses should be applied to the entire population or groups, and the booster doses interval, remains unclear. In this study, we evaluated humoral reactivity kinetics from before the first dose to 180 days after the third booster dose in different schedules in a well-controlled health worker cohort. Among the 2,506 employees, the first 500 vaccinated health workers were invited to participate. The third booster dose was administered 8 months after the first dose. Among the invited participants, 470 were included in the study; 258 received inactivated vaccine CoronaVac (VAC group) and 212 received viral vector vaccine ChAdOx1 (AZV group). The groups were homogeneous in terms of age and sex. 347 participants were followed up after the booster dose with AZV or BNT162b2 (Pfizer, BNT group): 63 with VAC/AZV, 117 with VAC/BNT, 72 with the AZV/AZV and 95 with AZV/BNT schedules. Blood samples were collected immediately before, 28 days after each dose and 180 days after the primary vaccination and booster dose. Anti-SARS-CoV-2 antibodies were measured by chemiluminescence and plaque reduction neutralization test (PRNT). Plasma immune mediators were quantified using a multiplex immunoassay. Geometric mean of antibodies increased 28 days after the second dose with 100 % seroconversion rate in both groups and decreased 180 days after the first dose. In the baseline-seropositive VAC group, the levels of plasma immune mediators increased after the second dose. Booster dose was applied at 4-6 months after the primary vaccination. Heterologous booster in VAC or AZV primary vaccinees were effective maintaining the titers of anti-SARS-CoV-2 antibodies even after 6 months of follow-up. The heterologous schedule induced higher and stable antibody reactivity, even after 180 days, protecting to ancestral (Wuhan), Delta, and Omicron variants.</AbstractText><CopyrightInformation>Copyright © 2023. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>da Penha Gomes Gouvea</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lira Machado</LastName><ForeName>Ketty Lysie Libardi</ForeName><Initials>KLL</Initials><AffiliationInfo><Affiliation>Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Yasmin Gurtler Pinheiro</ForeName><Initials>YGP</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moulaz</LastName><ForeName>Isac Ribeiro</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriques</LastName><ForeName>Allan Gonçalves</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouveia</LastName><ForeName>Thayná Martins</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Beatriz Paoli</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lança</LastName><ForeName>Karen Evelin Monlevade</ForeName><Initials>KEM</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza Ramos</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacerda</LastName><ForeName>Gabriela Curto Cristianes</ForeName><Initials>GCC</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenzi</LastName><ForeName>João Pedro Gonçalves</ForeName><Initials>JPG</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Castro Pimentel</LastName><ForeName>Felipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miossi</LastName><ForeName>João Pedro Moraes</ForeName><Initials>JPM</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rassele</LastName><ForeName>Matheus Leite</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camacho</LastName><ForeName>Luiz Antônio Bastos</ForeName><Initials>LAB</Initials><AffiliationInfo><Affiliation>Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villela</LastName><ForeName>Daniel Antunes Maciel</ForeName><Initials>DAM</Initials><AffiliationInfo><Affiliation>Programa de Computação Científica (PROCC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lima</LastName><ForeName>Sheila Maria Barbosa</ForeName><Initials>SMB</Initials><AffiliationInfo><Affiliation>Laboratório de Tecnologia Virológica (LATEV), Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza Azevedo</LastName><ForeName>Adriana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratório de Tecnologia Virológica (LATEV), Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horbach</LastName><ForeName>Ingrid Siciliano</ForeName><Initials>IS</Initials><AffiliationInfo><Affiliation>Laboratório de Tecnologia Virológica (LATEV), Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Araújo</LastName><ForeName>Mia Ferreira</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tort</LastName><ForeName>Luis Fernando Lopez</ForeName><Initials>LFL</Initials><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira</LastName><ForeName>Any Caroline Alves</ForeName><Initials>ACA</Initials><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siqueira</LastName><ForeName>Marilda Mendonça</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Cristiana Couto</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, MG, Brazil; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Costa-Rocha</LastName><ForeName>Ismael Artur</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campi-Azevedo</LastName><ForeName>Ana Carolina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peruhype-Magalhães</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Vanézia Gonçalves</ForeName><Initials>VG</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyamoto</LastName><ForeName>Samira Tatiyama</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dos Santos Fantoni</LastName><ForeName>Rosilene Nilo</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto-Neto</LastName><ForeName>Lauro Ferreira</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Escola de Ciências da Saúde da Santa Casa de Misericórdia, Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magda Domingues</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>External Consultant, Temporary Consulting of the Pan American Health Organization, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Medeiros Junior</LastName><ForeName>Nésio Fernandes</ForeName><Initials>NF</Initials><AffiliationInfo><Affiliation>Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil; Secretaria de Saúde do Estado do Espírito Santo, Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burian</LastName><ForeName>Ana Paula</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Secretaria de Saúde do Estado do Espírito Santo, Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teixeira-Carvalho</LastName><ForeName>Andréa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, MG, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mota</LastName><ForeName>Licia Maria Henrique</ForeName><Initials>LMH</Initials><AffiliationInfo><Affiliation>Hospital Universitário de Brasília, Universidade de Brasília (UnB), Brasília, DF, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mill</LastName><ForeName>José Geraldo</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins-Filho</LastName><ForeName>Olindo Assis</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, MG, Brazil. Electronic address: oamfilho@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valim</LastName><ForeName>Valéria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil. Electronic address: val.valim@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BNT162b2</Keyword><Keyword MajorTopicYN="N">Booster dose</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ChAdOx1 nCov-19</Keyword><Keyword MajorTopicYN="N">CoronaVac</Keyword><Keyword MajorTopicYN="N">Vaccine</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>1</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37661534</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2023.08.022</ArticleId><ArticleId IdType="pii">S0264-410X(23)00954-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle>